Compendium of Cancer Genome Aberrations

Volunteer Assignments and Opportunities: Difference between revisions

← Older editNewer edit →
VisualWikitext
No edit summary
Snehal.Patel (talk | contribs)
editor
270 edits
No edit summary
(166 intermediate revisions by 6 users not shown)
Line 1: Line 1:


{| class="wikitable"
{| class="wikitable"
|+WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues Content
|-
|-
|'''Disease'''||'''Page Type'''||'''Author'''||'''Associate Editor'''
!'''Disease'''!!'''Page Type'''!!'''Author'''
!Author Content (Pending or Complete)
!'''Date Assigned to Author'''
!Editor Reviewed (Date)
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''!!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''|| ||Fabiola Quintero-Rivera (FQR)
|'''''Myeloproliferative Neoplasms (MPN)'''''||'''''Overview'''''||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|complete
|
|Fabiola Quintero-Rivera (FQR)
|
|
|
|
|-
|-
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
|    Chronic Myeloid  Leukemia (CML), BCR-ABL1-Positive||Disease
| ||FQR
|Mark Evans (trainee)+Jack Reid (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|FQR
|
|
|
|
|-
|-
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
|    Chronic Neutrophilic  Leukemia (CNL)||Disease
| ||FQR
|Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|FQR
|
|
|
|
|-
|-
|    Polycythaemia Vera  (PV)||Disease
|    Polycythaemia Vera  (PV)||Disease
| ||FQR
|Gokce A. Toruner
|
|
|complete
|
|FQR
|
|
|
|
|-
|-
|    Primary Myelofibrosis  (PMF)||Disease
|    Primary Myelofibrosis  (PMF)||Disease
| ||FQR
|T. Niroshi  Senaratne
|
|
|complete
|
|
|FQR
|8/4/2020 before submission
|
|
|-
|-
|    Essential  Thrombocythaemia (ET)||Disease
|    Essential  Thrombocythaemia (ET)||Disease
| ||FQR
|Rebecca Smith (trainee) + Fabiola Quintero-Rivera
|
|
|complete/pending faculty review
|
|FQR
|
|
|
|
|-
|-
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
|    Chronic Eosinophilic  Leukemia, Not Otherwise Specified||Disease
| ||FQR
|(trainee), Daynna J.Wolff
|
|
|pending faculty review
|
|FQR
|
|
|
|
|-
|-
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
|    Myeloproliferative  Neoplasm (MPN), Unclassifiable||Disease
| ||FQR
|Thomas Lee
|8/17/2020
|9/7/2020
|complete
|
|FQR
|
|
|
|
|-
|-
|'''''Mastocytosis'''''||'''''Overview'''''|| ||FQR
|'''''Mastocytosis'''''||'''''Overview'''''||'''Shashi Shetty, Ph.D.'''
|
|
|complete
| ||FQR
|
|
|
|
|-
|-
|    Cutaneous  Mastocytosis||Disease
|    Cutaneous  Mastocytosis||Disease
| ||FQR
|Thuy Phung/Shuo-Shawn Liu
|
|
|complete/pending adding content online as of 2/4/21
|
|FQR
|
|
|
|
|-
|-
|    Systemic Mastocytosis||Disease
|    Systemic Mastocytosis||Disease
| ||FQR
|Shashi Shetty
|
|
|complete
|
|FQR
|
|
|
|
|-
|-
|    Mast Cell Sarcoma||Disease
|    Mast Cell Sarcoma||Disease
| ||FQR
|Thuy Phung +Jordan Lowery
|
|
|complete
|
|FQR
|
|
|-
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement  of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''||Daynna J.Wolff
|
|
|complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRA Rearrangement||Disease||Jay Alden  (trainee) +Daynna J.Wolff
|
|
|Complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease||Christopher Sullivan (trainee) + Daynna J.Wolff
|
|
|Complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with FGFR1 Rearrangement||Disease||Yanna Ding
|
|
|Complete
|
|FQR
|
|
|-
|    Myeloid/Lymphoid  Neoplasms with PCM1-JAK2||Disease||Jessica Snider (trainee) + Daynna J.Wolff
|
|
|Complete
|
|FQR
|
|
|-
|Myeloid/Lymphoid Neoplasms with ETV6-JAK2
|Disease
|Lauren R. Crowson (trainee)-Hindman + Daynna J. Wolff
|
|
|Complete
|
|FQR
|
|NON-WHO ENTITY
|-
|Myeloid/Lymphoid Neoplasms with BCR-JAK2
|Disease
|Lauren R. Crowson (trainee) + Daynna J. Wolff
|
|
|Complete
|
|FQR
|
|NON-WHO ENTITY
|-
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''||Linsheng Zhang
|
|
|Complete
|
|FQR
|
|
|-
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease||Linsheng Zhang
|
|
|Complete
|
|FQR
|
|
|-
|    Atypical Chronic  Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease||Linsheng Zhang
|
|
|Complete
|
|FQR
|
|
|-
|    Juvenile  Myelomonocytic Leukemia (JMML)||Disease||Sarah Rapisardo
|
|9/1/20
|PENDING
|
|FQR
|
|
|-
|     Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts  and Thrombocytosis (MDS/MPN-RS-T)||Disease||Anamaria Munteanu (trainee)+Fabiola Quintero-Rivera
|
|
|complete
|
|FQR
|
|
|-
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease||Ruth MacKinnon
|
|
|complete
|
|FQR
|
|
|-
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''||Teresa Smolarek?
|
|9/1/20
|pending
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome (MDS) with Single Lineage Dysplasia||Disease||Xiaoli Du(trainee) +Teresa Smolarek
|
|9/1/20
|PENDING
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome with Ring Sideroblasts (MDS-RS)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|Complete
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|Complete
|
|FQR
|
|
|-
|    Myelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|9/1/20
|PENDING
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|9/1/20
|PENDING
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|Complete
|
|FQR
|
|
|-
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease||Xiaolin Hu(trainee)+Teresa Smolarek
|
|
|complete
|
|FQR
|
|
|-
|    Refractory Cytopenia  of Childhood||Disease||Xiaoli Du(trainee)+Teresa Smolarek
|
|9/1/20
|PENDING
|
|FQR
|
|
|-
| || ||
|
|
|
| ||
|
|
|-
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''||Daynna Wolff+Daniel Butler (Path Resident)
|
|
|Complete
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|04/26/2021 -MS (re-review)
|
|-
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''||Ying  Zou
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease||Daynna Wolff+Matthew Kilpatrick (Path Resident)
|
|
|PENDING
| ||JH / MS
|04/26/2021 -MS (re-review)
|
|-
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|03/01/2021-MS
|
|-
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease||Malini Sathanoori
|
|
|Complete
|02/03/2021||JH / MS
|
|
|-
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|03/02/2021-MS
|
|-
|    Myeloid Neoplasms with Germline ETV6  Mutation||Disease||Ying Zou
|
|
|Complete
| ||JH / MS
|03/02/2021-MS (re-review)
|
|-
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease||Daynna Wolff+ Alexandria Avery (Path Resident)
|
|
|Complete
| ||JH / MS
|04/26/2021 -MS (re-review)
|
|-
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''||Daynna Wolff+ Dan Wang (trainee)
|
|
|Complete
|
|JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease||Christine Bryke
|
|
|Complete
| ||JH / MS
|04/26/2021-MS (re-review)
|
|-
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Promyelocytic Leukemia (APL) with  PML-RARA||Disease||Shashi Shetty
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Myeloid Leukemia (AML) with  t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease||Shashi Shetty
|
|
|Complete
| ||JH / MS
|03/01/2021-MS (re-review)
|
|-
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
|02/24/2021-MS (re-review)
|
|-
|    Acute Myeloid Leukemia (AML) with  inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease||Gordana Raca
|
|
|Complete
| ||JH / MS
|
|Need permission for figure?  Update WHO?
|-
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease||Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid Leukemia (AML) with  Mutated NPM1||Disease||Xinjie Xu+Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|Complete
| ||JH / MS
|
|Add WHO reference
|-
|    Acute Myeloid Leukemia (AML) with  Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc + Greg  Conboy (Monash Health)
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid Leukemia (AML) with  Mutated RUNX1||Disease||Daynna Wolff+Iris Martin (Path Resident)
|
|
|Complete
| ||JH / MS
|
|
|-
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|
|
|-
|Therapy-Related Myeloid Neoplasms||Disease||Shashi Shetty + Shawn A. Silver (resident)
|
|
|Complete
| ||JH / MS
|
|Check reference format
|-
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''||Anwar Iqbal
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease||Fabiola Quintero-Rivera and Celeste Eno (fellow)
|
|
|Complete
| ||JH / MS
|
|
|-
|   Acute Myeloid Leukemia (AML) without Maturation||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myeloid Leukemia (AML) with Maturation||Disease||Jennelle Hodge
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Myelomonocytic Leukemia||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Monoblastic and Monocytic Leukemia||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|
|
|-
|    Pure Erythroid Leukemia||Disease||Ash  Yenamandra
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease||Fei Yang
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Basophilic Leukemia||Disease||Ash Yenamandra
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute Panmyelosis with Myelofibrosis||Disease||Ying Zou and Jialing Huang (MGP fellow)
|
|
|Complete
| ||JH / MS
|
|
|-
|Myeloid Sarcoma||Disease||Fabiola Quintero-Rivera
|
|
|Complete
| ||JH / MS
|
|
|-
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''||Patty  Greipp
|
|
|Complete
| ||JH / MS
|
|Need permission for figure?
|-
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease||Linda Cooley
|
|
|Complete
| ||JH / MS
|
|
|-
|    Myeloid Leukemia Associated with Down  Syndrome||Disease||Linda Cooley
|
|
|Complete
| ||JH / MS
|
|
|-
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease||Daynna Wolff+Hao Liu (Path Resident)
|
|
|Complete
| ||JH / MS
|
|
|-
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''||Hui Chen/ Jennelle Hodge
|
|
|Complete
| ||JH / MS
|
|
|-
|    Acute  Undifferentiated Leukemia||Disease||Shashi Shetty + Amelia Nakanishi (resident)
|
|
|Complete
| ||JH / MS
|
|Check reference format
|-
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease||Tracy Tucker
|
|
|Complete
| ||JH / MS
|
|
|-
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease||Tracy Tucker
|
|
|Complete
| ||JH / MS
|
|
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease||Shashi Shetty + Priyatharsini Nirmalanantham (resident)
|
|
|Complete
| ||JH / MS
|
|
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  T/Myeloid, Not Otherwise Specified||Disease||Fabiola Quintero-Rivera
|
|
|Complete
| ||JH / MS
|
|
|
|
|-
|-
|'''''Myeloid/Lymphoid Neoplasms with Eosinophilia and Rearrangement of PDGFRA, PDGFRB or FGFR1, or with PCM1-JAK2'''''||'''''Overview'''''|| ||FQR
|    Mixed-Phenotype Acute Leukemia, Not Otherwise Specified (NOS), Rare Types||Disease||Daynna Wolff+ Elicia Goodale (resident)
|
|
|PENDING
| ||JH / MS
|
|
|
|
|-
|-
|    Myeloid/Lymphoid Neoplasms with PDGFRA Rearrangement||Disease|| ||FQR
|    Acute Leukemias of Ambiguous Lineage, Not Otherwise Specified (NOS)||Disease||Daynna Wolff+Madison Hannay or Elicia Goodale (residents)
|
|
|PENDING
| ||JH / MS
|
|
|
|
|-
|-
|    Myeloid/Lymphoid  Neoplasms with PDGFRB Rearrangement||Disease|| ||FQR
|Acute  Myeloid Leukemia (AML) with Mutated FLT3
|Disease
|Kay Weng Choy + Greg Conboy (Monash Health)
|
|
|
|
|Complete
|
|JH / MS
|
|NON-WHO ENTITY
|-
|-
|    Myeloid/Lymphoid Neoplasms with FGFR1 Rearrangement||Disease|| ||FQR
|Acute Myeloid Leukemia (AML) with NUP214-ABL1
|Disease
|Daynna Wolff+Jessica Snider (Path Resident)
|
|
|
|
|PENDING
|
|JH / MS
|
|NON-WHO ENTITY
|-
|-
|    Myeloid/Lymphoid Neoplasms with PCM1-JAK2||Disease|| ||FQR
|Acute Myeloid Leukemia (AML) with t(4;12)(q12;p13); CHIC2-ETV6
|Disease
|Daynna Wolff+ Paige Woodham (Path Resident)
|
|
|
|
|PENDING
|
|JH / MS
|
|NON-WHO ENTITY
|-
|-
|'''''Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN)'''''||'''''Overview'''''|| ||FQR
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|    Chronic  Myelomonocytic Leukemia (CMML)||Disease|| ||FQR
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||Yassmine Akkari (YA)
|
|
|
|
|-
|-
|    Atypical Chronic Myeloid Leukemia (aCML), BCR-ABL1 Negative||Disease|| ||FQR
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic Abnormalities'''''||'''''Overview'''''||
|
|
|
| ||YA
|
|
|
|
|-
|-
|    Juvenile Myelomonocytic Leukemia (JMML)||Disease|| ||FQR
|    B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease||Afia Hasnain + Yassmine Akkari
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|    Myelodysplastic/Myeloproliferative Neoplasms with Ring Sideroblasts and Thrombocytosis (MDS/MPN-RS-T)||Disease|| ||FQR
|    B-Lymphoblastic Leukemia/Lymphoma with  t(v;11q23.3); KMT2A-Rearranged||Disease||Yassmine Akkari+Nicolas Millan (trainee)
|
|
|PENDING
|
|YA
|
|
|
|
|-
|-
|     Myelodysplastic/Myeloproliferative Neoplasms (MDS/MPN), Unclassifiable||Disease|| ||FQR
|    B-Lymphoblastic Leukemia/Lymphoma with t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease||Marilena Melas + Yassmine Akkari
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|'''''Myelodysplastic Syndromes (MDS)'''''||'''''Overview'''''|| ||FQR
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease||Afia Hasnain + Yassmine Akkari
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|    Myelodysplastic Syndrome (MDS) with Single Lineage Dysplasia||Disease|| ||FQR
|    B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy||Disease||Ashwini Yenamandra +
 
Lisa Smith + Yassmine Akkari
|
|
|Complete
|
|YA
|
|
|
|
|-
|-
|    Myelodysplastic Syndrome with Ring Sideroblasts (MDS-RS)||Disease|| ||FQR
|    B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3||Disease||Binu Porath + Linda Cooley
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|    Myelodysplastic Syndrome with Ring Sideroblasts and Multilineage Dysplasia||Disease|| ||FQR
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease||Binu Porath + Linda Cooley
|
|
|PENDING
| ||YA
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like||Disease||Mark G. Evans + Fabiola Quintero-Rivera
|
|
|Complete
|
|YA
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma with iAMP21||Disease||Holli Drendel
|
|
|PENDING
| ||YA
|
|
|-
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||Holli Drendel
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|    Myelodysplastic  syndrome with multilineage dysplasiaMyelodysplastic Syndrome (MDS) with  Multilineage Dysplasia||Disease|| ||FQR
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
|Disease
|Diana Rush
|
|
|
|PENDING
|
|
|YA
|
|NON-WHO ENTITY
|-
|-
|    Myelodysplastic  Syndrome (MDS) with Excess Blasts||Disease|| ||FQR
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
|Disease
|Celeste Eno
|
|
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|-
|    Myelodysplastic  Syndrome (MDS) with Isolated del(5q)||Disease|| ||FQR
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|Disease
|Marilena Melas
|
|
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|-
|    Myelodysplastic  Syndrome (MDS), Unclassifiable||Disease|| ||FQR
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
|Disease
|Chenkai Ma
|
|
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
|    Refractory Cytopenia  of Childhood||Disease|| ||FQR
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
|Disease
|Celeste Eno
|
|
|PENDING
|
|
|YA
|
|
|NON-WHO ENTITY
|-
|-
| || || ||
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
|Disease
|Alaa Koleilat
|
|
|
|
|PENDING
|
|YA
|
|NON-WHO ENTITY
|-
|-
|'''''Acute Myeloid Leukemia (AML) and Related Precursor Neoplasms'''''||'''''Overview'''''|| ||Jennelle Hodge (JH)
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|'''''Myeloid Neoplasms with Germline Predisposition'''''||'''''Overview'''''|| ||JH
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|    Acute Myeloid  Leukaemia with Germline CEBPA Mutation||Disease|| ||JH
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
|
|
|PENDING
| ||YA
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline DDX41  Mutation||Disease|| ||JH
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline RUNX1  Mutation||Disease|| ||JH
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||Snehal Patel (SP)
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline ANKRD26  Mutation||Disease|| ||JH
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||
|
|
|
|
|SP
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline ETV6 Mutation||Disease|| ||JH
|       Monoclonal B-cell Lymphocytosis||Disease||
|
|
|
|
|SP
|
|
|
|
|-
|-
|    Myeloid Neoplasms with Germline GATA2  Mutation||Disease|| ||JH
|B-cell Prolymphocytic Leukemia||Disease||
|
|
|
|
|SP
|
|
|
|
|-
|-
|'''''Acute Myeloid Leukemia (AML) with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''|| ||JH
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|
|
|-
|-
|    Acute Myeloid  Leukemia (AML) with t(8;21)(q22;q22.1); RUNX1-RUNX1T1||Disease|| ||JH
|Hairy Cell Leukemia||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease|| ||JH
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|
|
|Complete
|
|SP
|
|
|
|
|-
|-
|    Acute Promyelocytic Leukemia (APL) with PML-RARA||Disease|| ||JH
|    Splenic Diffuse Red Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with t(9;11)(p21.3;q23.3); KMT2A-MLLT3||Disease|| ||JH
|    Hairy Cell Leukemia  Variant||Disease||Snehal Patel
|
|
|Complete
|
|SP
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  t(6;9)(p23;q34.1); DEK-NUP214||Disease|| ||JH
|Lymphoplasmacytic Lymphoma||Disease||
|
|
|
|
|SP
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2);GATA2, MECOM||Disease|| ||JH
|   Waldenstrom Macroglobulinemia||Disease||
|
|
|
|
|SP
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML)  Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease|| ||JH
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with  BCR-ABL1||Disease|| ||JH
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with Mutated NPM1||Disease|| ||JH
|    Mu Heavy Chain Disease||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA||Disease|| ||JH
|   Gamma Heavy Chain Disease||Disease||Manisha Sutariya
|
|
|Complete
|5/26/2021||SP
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with Mutated RUNX1||Disease|| ||JH
|    Alpha Heavy Chain Disease||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes||Disease|| ||JH
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Therapy-Related Myeloid Neoplasms||Disease|| ||JH
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|''Acute Myeloid Leukemia (AML), Not Otherwise Specified''||'''''Overview'''''|| ||JH
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|    Acute Myeloid  Leukemia (AML) with Minimal Differentiation||Disease|| ||JH
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|   Acute Myeloid Leukemia (AML) without  Maturation||Disease|| ||JH
|    Plasmacytoma||Disease||Zhenya Tang
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|    Acute Myeloid Leukemia (AML) with Maturation||Disease|| ||JH
|'''''    Monoclonal Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Acute Myelomonocytic Leukemia||Disease|| ||JH
|           Primary  Amyloidosis||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Acute Monoblastic and Monocytic Leukemia||Disease|| ||JH
|           Light Chain  and Heavy Chain Deposition Disease||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Pure Erythroid Leukemia||Disease|| ||JH
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Acute Megakaryoblastic Leukemia (AMKL)||Disease|| ||JH
|         POEMS Syndrome||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Acute Basophilic Leukemia||Disease|| ||JH
|         TEMPI Syndrome||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Acute Panmyelosis with Myelofibrosis||Disease|| ||JH
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Whayoung Lee, trainee)/Fabiola Quintero-Rivera
|3/9/21
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Myeloid Sarcoma||Disease|| ||JH
|Nodal Marginal Zone Lymphoma||Disease||Shivani Golem
|
|
|Complete
|5/28/2021||SP
|
|
|
|
|-
|-
|'''''Myeloid Proliferations Associated with Down Syndrome'''''||'''''Overview'''''|| ||JH
|    Paediatric Nodal  Marginal Zone Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|Complete
|11/11/2020
|SP
|
|
|
|
|-
|-
|    Transient Abnormal Myelopoiesis (TAM)  Associated with Down Syndrome||Disease|| ||JH
|Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|    Myeloid Leukemia Associated with Down Syndrome||Disease|| ||JH
|    Testicular Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Blastic Plasmacytoid Dendritic Cell Neoplasm||Disease|| ||JH
|    In Situ Follicular  Neoplasia||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|'''''Acute Leukemias of Ambiguous Lineage'''''||'''''Overview'''''|| ||JH
|    Duodenal-Type  Follicular Lymphoma||Disease||Ruthann Pfau
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|    Acute  Undifferentiated Leukemia||Disease|| ||JH
|Paediatric-Type Follicular Lymphoma||Disease||Ruthann Pfau, Kathleen Schieffer (trainee)
|
|
|Complete
|8/16/2020
|SP
|
|
|
|
|-
|-
|    Mixed Phenotype Acute  Leukemia (MPAL) with t(9;22)(q34.1;q11.2); BCR-ABL1||Disease|| ||JH
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease||Afia Hasnaid
|
|9/30/20
|Complete
|5/26/2021||SP
|
|
|
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL)  with t(v;11q23.3); KMT2A Rearranged||Disease|| ||JH
|Primary Cutaneous Follicle Centre Lymphoma||Disease||Shivani Golem
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL),  B/Myeloid, Not Otherwise Specified||Disease|| ||JH
|Mantle Cell Lymphoma||Disease||Mahsa Khanlari
|
|8/15/20
|PENDING
|
|SP
|
|
|
|
|-
|-
|    Mixed Phenotype Acute Leukemia (MPAL), T/Myeloid, Not Otherwise Specified||Disease|| ||JH
|    Leukemic Non-Nodal Mantle Cell Lymphoma||Disease||
|
|
|
|
|SP
|
|
|
|
|-
|-
|    ??Mixed-Phenotype Acute Leukaemia, Not Otherwise Specified (NOS), Rare Types||Disease|| ||JH
|    In Situ Mantle Cell Neoplasia||Disease||
|
|
|
|
|SP
|
|
|
|
|-
|-
|    ??Acute Leukaemias of Ambiguous Lineage,  Not Otherwise Specified (NOS)||Disease|| ||JH
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
| || || ||
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease||Ashwini Yenamandra
|
|
|PENDING
|
|Greg Corboy (GC)
|
|
|
|
|-
|-
|'''''Precursor Lymphoid Neoplasms'''''||'''''Overview'''''|| ||Yassmine Akkari (YA)
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|'''''B-Lymphoblastic Leukemia/Lymphoma with Recurrent Genetic  Abnormalities'''''||'''''Overview'''''|| ||YA
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|    B-Lymphoblastic  Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1    ||Disease|| ||YA
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged||Disease|| ||YA
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(12;21)(p13.2;q22.1); ETV6-RUNX1||Disease|| ||YA
|EBV-Positive Mucocutaneous Ulcer||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hyperdiploidy||Disease|| ||YA
|Diffuse Large B-cell Lymphoma Associated with Chronic Inflammation||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  Hypodiploidy||Disease|| ||YA
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(5;14)(q31.1;q32.1); IGH/IL3||Disease|| ||YA
|Lymphomatoid Granulomatosis||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  t(1;19)(q23;p13.3); TCF3-PBX1||Disease|| ||YA
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma,  BCR-ABL1-Like||Disease|| ||YA
|Intravascular Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma with  iAMP21||Disease|| ||YA
|ALK-Positive Large B-cell Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease|| ||YA
|Plasmablastic Lymphoma||Disease||Mark Evans (trainee), Fabiola Quintero-Rivera
|
|
|Complete
| ||GC
|
|
|
|
|-
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''|| ||YA
|Primary Effusion Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease|| ||YA
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease|| ||YA
|   Multicentric Castleman  Disease||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
| || || ||
|   HHV8-Positive Diffuse  Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''|| ||Snehal Patel (SP)
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease|| ||SP
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
|3/11/21
|
|PENDING
| ||GC
|
|
|
|
|-
|-
|       Monoclonal B-cell  Lymphocytosis||Disease|| ||SP
|Burkitt-Like Lymphoma with 11q Aberration||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|B-cell Prolymphocytic Leukemia||Disease|| ||SP
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Splenic Marginal Zone Lymphoma||Disease|| ||SP
|    High-Grade B-cell  Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Hairy Cell Leukemia||Disease|| ||SP
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''|| ||SP
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease|| ||SP
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|    Hairy Cell Leukemia  Variant||Disease|| ||SP
|'''''Mature T- and NK-cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||Snehal Patel (SP)
|
|
|
|
|-
|-
|Lymphoplasmacytic Lymphoma||Disease|| ||SP
|T-cell Prolymphocytic Leukemia||Disease||Michelle Don
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|   Waldenstrom  Macroglobulinemia||Disease|| ||SP
|T-cell Large Granular Lymphocytic Leukemia||Disease||Michelle Don
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| ||SP
|Chronic Lymphoproliferative Disorder of NK Cells||Disease||Michelle Don
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|'''''Heavy Chain Diseases'''''||'''''Overview'''''|| ||SP
|Aggressive NK-cell Leukemia||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Mu Heavy Chain Disease||Disease|| ||SP
|'''''EBV-Positive T-cell and NK-cell Lymphoproliferative Diseases of Childhood'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|
|
|-
|-
|   Gamma Heavy Chain Disease||Disease|| ||SP
|  Systemic EBV-Positive T-cell Lymphoma of Childhood||Disease||Lisa Lansdon (trainee)
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|    Alpha Heavy Chain Disease||Disease|| ||SP
|   Chronic Active EBV Infection of T- and NK-cell Type, Systemic Form||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Plasma Cell Neoplasms||'''''Overview'''''|| ||SP
|    Hydroa  Vacciniforme-Like Lymphoproliferative Disorder||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|   Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease|| ||SP
|    Severe Mosquito Bite Allergy||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Plasma Cell Myeloma||Disease|| ||SP
|Adult T-cell Leukemia/Lymphoma||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Plasma Cell Myeloma  Variants||Disease|| ||SP
|Extranodal NK/T-cell Lymphoma, Nasal Type||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Plasmacytoma||Disease|| ||SP
|'''''Intestinal T-cell Lymphoma'''''||'''''Overview'''''||Sumire Kitahara, Derick Okwan (trainee)
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''|| ||SP
|      Enteropathy-Associated T-cell Lymphoma||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|Complete
|1/21/2021
|SP
|
|
|
|
|-
|-
|           Primary Amyloidosis||Disease|| ||SP
|     Monomorphic Epitheliotropic Intestinal T-cell Lymphoma||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|           Light Chain and Heavy Chain Deposition Disease||Disease|| ||SP
|     Intestinal T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|'''''Plasma Cell Neoplasms with Associated Paraneoplastic Syndrome'''''||'''''Overview'''''|| ||SP
|    Indolent T-cell  Lymphoproliferative Disorder of the Gastrointestinal Tract||Disease||Sumire Kitahara, Derick Okwan (trainee)
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|         POEMS Syndrome||Disease|| ||SP
|Hepatosplenic T-cell Lymphoma||Disease||Michelle Don
|
|
|Complete
|1/21/2021
|SP
|
|
|
|
|-
|-
|         TEMPI Syndrome||Disease|| ||SP
|Subcutaneous Panniculitis-Like T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease|| ||SP
|Mycosis Fungoides||Disease||Daynna Wolff, Jane Scribner (trainee)
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|Nodal Marginal Zone Lymphoma||Disease|| ||SP
|Sézary Syndrome||Disease||Daynna Wolff, Madison Hannay (trainee)
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|    Paediatric Nodal Marginal Zone Lymphoma||Disease|| ||SP
|'''''Primary Cutaneous CD30 Positive T-cell Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Follicular Lymphoma||Disease|| ||SP
|    Lymphomatoid  Papulosis||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Testicular Follicular Lymphoma||Disease|| ||SP
|    Primary Cutaneous Anaplastic Large Cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|    In Situ Follicular  Neoplasia||Disease|| ||SP
|'''''Primary Cutaneous Peripheral T-cell Lymphomas, Rare Subtypes'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Duodenal-Type  Follicular Lymphoma||Disease|| ||SP
|     Primary Cutaneous  Gamma Delta T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Paediatric-Type Follicular Lymphoma||Disease|| ||SP
|     Primary Cutaneous  CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Large B-cell Lymphoma with IRF4 Rearrangement||Disease|| ||SP
|     Primary Cutaneous  Acral CD8+ T-cell Lymphoma||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Primary Cutaneous Follicle Centre Lymphoma||Disease|| ||SP
|     Primary Cutaneous CD4+ Small/Medium T-cell Lymphoproliferative Disorder||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|Mantle Cell Lymphoma||Disease|| ||SP
|Peripheral T-cell Lymphoma, Not Otherwise Specified (NOS)||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|-
|    Leukemic Non-Nodal  Mantle Cell Lymphoma||Disease|| ||SP
|'''''Angioimmunoblastic T-cell Lymphoma and Other Nodal Lymphomas of T Follicular Helper Cell Origin'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|
|
|-
|-
|    In Situ Mantle Cell Neoplasia||Disease|| ||SP
|     Angioimmunoblastic T-cell Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
| || || ||
|    Follicular T-cell  Lymphoma||Disease||Ruthann Pfau, Sara Akhavanfard (trainee)
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Diffuse Large B-cell Lymphoma, Not Otherwise Specified||Disease|| ||Greg Corboy (GC)
|     Nodal Peripheral  T-cell Lymphoma with T Follicular Helper Phenotype||Disease||Hans Hamnvåg
|
|
|PENDING
| ||SP
|
|
|
|
|-
|-
|T-cell/Histiocyte-Rich Large B-cell Lymphoma||Disease|| ||GC
|Anaplastic Large Cell Lymphoma, ALK-Positive||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Primary Diffuse Large B-cell Lymphoma of the CNS||Disease|| ||GC
|Anaplastic Large Cell Lymphoma, ALK-Negative||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|Primary Cutaneous Diffuse Large B-cell Lymphoma, Leg Type||Disease|| ||GC
|Breast Implant-Associated Anaplastic Large Cell Lymphoma||Disease||Sumire Kitahara
|
|
|PENDING
|
|SP
|
|
|
|
|-
|-
|EBV-Positive Diffuse Large B-cell Lymphoma, Not Otherwise  Specified (NOS)||Disease|| ||GC
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|EBV-Positive Mucocutaneous Ulcer||Disease|| ||GC
|'''''Hodgkin Lymphomas'''''||'''''Overview'''''||
|
|
|
| ||Greg Corboy (GC)
|
|
|
|
|-
|-
|Diffuse Large B-cell Lymphoma Associated with Chronic  Inflammation||Disease|| ||GC
|Nodular Lymphocyte Predominant Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|    Fibrin-Associated  Diffuse Large B-cell Lymphoma||Disease|| ||GC
|'''''Classic Hodgkin Lymphoma'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Lymphomatoid Granulomatosis||Disease|| ||GC
|    Nodular Sclerosis  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Primary Mediastinal (Thymic) Large B-cell Lymphoma||Disease|| ||GC
|    Lymphocyte-Rich  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Intravascular Large B-cell Lymphoma||Disease|| ||GC
|    Mixed Cellularity  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|ALK-Positive Large B-cell Lymphoma||Disease|| ||GC
|    Lymphocyte-Depleted  Classic Hodgkin Lymphoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Plasmablastic Lymphoma||Disease|| ||GC
|'''''Immunodeficiency-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Primary Effusion Lymphoma||Disease|| ||GC
|Lymphomas Associated with HIV Infection||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|'''''HHV8-Associated Lymphoproliferative Disorders'''''||'''''Overview'''''|| ||GC
|'''''Post-Transplant Lymphoproliferative Disorders'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|   Multicentric Castleman Disease||Disease|| ||GC
|    Non-Destructive Post-Transplant Lymphoproliferative Disorders||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|   HHV8-Positive Diffuse Large B-cell Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
|    Polymorphic Post-Transplant Lymphoproliferative Disorders||Disease||Anna Shestakova (trainee)''+,''
 
Fabiola Quintero-Rivera
|
|
|PENDING
|
|GC
|
|
|
|
|-
|-
|   HHV8-Positive  Germinotropic Lymphoproliferative Disorder||Disease|| ||GC
|'''''    Monomorphic  Post-Transplant Lymphoproliferative Disorders (B- and T/NK-cell Types)'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Burkitt Lymphoma||Disease|| ||GC
|          Monomorphic  B-cell PTLD||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Burkitt-Like Lymphoma with 11q Aberration||Disease|| ||GC
|          Monomorphic  T/NK-cell PTLD||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|'''''High-Grade B-cell Lymphoma'''''||'''''Overview'''''|| ||GC
|    Classical Hodgkin  Lymphoma Post-Transplant Lymphoproliferative Disorder||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|    High-Grade B-cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements||Disease|| ||GC
|Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|    High-Grade B-cell  Lymphoma, Not Otherwise Specified (NOS)||Disease|| ||GC
|'''''Histiocytic and Dendritic Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|B-cell Lymphoma, Unclassifiable, with Features Intermediate  Between Diffuse Large B-cell Lymphoma and Classic Hodgkin Lymphoma||Disease|| ||GC
|Histiocytic Sarcoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
| || || ||
|'''''Tumors Derived From Langerhans Cells'''''||'''''Overview'''''||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||Associate Editor??
|   Langerhans Cell  Histiocytosis||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||
|   Langerhans Cell  Sarcoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||
|Indeterminate Dendritic Cell Tumour||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||
|Interdigitating Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||
|Follicular Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||
|Fibroblastic Reticular Cell Tumor||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||
|Disseminated Juvenile Xanthogranuloma||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||
|Erdheim-Chester Disease||Disease||
|
|
|
| ||GC
|
|
|
|
|-
|-
|Example||Example|| ||
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||
| || ||
|
|
|
| ||
|
|
|
|
|-
|-
|Example||Example|| ||
| || ||
|
|
|
|
| ||
|
|
|
|}
{| class="wikitable sortable"
|+Gene-Specific Pages
!'''Gene'''
!'''Author'''
!'''Date Assigned to Author'''
!'''Target Completion Date'''
!'''Author Content (Pending or Complete)'''
!'''Date Completed by Author'''
!'''Associate Editor'''
!'''Date of Last Editor Review'''
!'''Notes'''
|-
|-
|Example||Example|| ||
|BCR
|Brian Davis
|
|
|Complete
|8/10/18
|
|
|
|
|
|-
|-
|Example||Example|| ||
|ABL1
|Brian Davis
|
|
|Complete
|4/16/19
|
|
|
|
|
|-
|-
|Example||Example|| ||
|RUNX1
|Brian Davis
|
|
|Complete
|6/9/19
|
|
|
|
|
|-
|-
|Example||Example|| ||
|RUNX1T1
|Brian Davis
|
|
|Complete
|5/23/19
|
|
|
|
|
|-
|-
|Example||Example|| ||
|MYH11
|Brian Davis
|
|
|Complete
|8/6/18
|
|
|
|
|
|-
|-
|Example||Example|| ||
|FLT3
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|NPM1
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|TP53
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|DNMT3A
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|CEBPA
|Gordana
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|IDH1
|Paul De Fazio
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|IDH2
|Paul De Fazio
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|PML
|Brian Davis
|
|
|Complete
|12/5/18
|
|
|
|
|
|-
|-
|Example||Example|| ||
|RARA
|Brian Davis
|
|
|Complete
|8/3/18
|
|
|
|
|
|-
|-
|Example||Example|| ||
|ETV6
|Brian Davis
|
|
|Complete
|6/9/19
|
|
|
|
|
|-
|-
|Example||Example|| ||
|KIT
|Brian Davis
|
|
|Complete
|10/1/18
|
|
|
|
|
|-
|-
|Example||Example|| ||
|CBFB
|Brian Davis
|
|
|Complete
|8/2/18
|
|
|
|
|
|-
|-
|Example||Example|| ||
|GATA2
|Kay Weng Choy
|
|
|Complete
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|PTEN
|Beth Pitel
|
|
|Pending
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|MLTT3
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|MECOM
|Brian Davis
|
|
|Pending
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|FGFR1(FLT2)
|Brian Davis
|
|
|Pending
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|KMT2A
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|DEK
|Wahab A. Khan
|
|
|Pending
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|NUP214
|Wahab A. Khan
|
|
|Pending
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|RBM15
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|MKL1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|DDX41
|Ying Zou
|8/7/20
|
|Pending
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|ANKRD26
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|CUX1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|TET2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|EZH2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|FOXP1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|MYC
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|JAK2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|WT1
|DONE
|
|
|DONE
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|CBL
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|NF1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|SUZ12
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|ERG
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|EST2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|RPS14
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|RB1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|MPL
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|CHGA
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|CDH1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|SRSF2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|DNMT1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|PRDX2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|ASXL1
|DONE
|
|
|DONE
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|MN1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|SF3A1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|EP300
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|JARID2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|BRCA1
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|BRCA2
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|
|
|
|
|
|
|
|
|
|
|
|-
|-
|Example||Example|| ||
|
|
|
|
|
|
|
|
|
|
|
|}
|}
Retrieved from "https://test.ccga.io/index.php/Volunteer_Assignments_and_Opportunities"